Note: Ingredients listed on restricted chemical lists
EC/CAS
240-440-2/16389-88-1
Name of the chemical
dolomite
Concentration
≥50
General Information
Version
1.0
Revision date
2022-12-12
Product name
BARTOLINE WALL TILE GROUT
1.2.1 Relevant identified uses
Wall tile grout powder
1.2.2. Uses advised against
Not to be used for making casts of body parts, during setting the product may heat up causing skin burns
Manufacturer Name
Bartoline Limited Ltd
Emergency telephone
+353 1 809 2566, +353 1 809 2166
Icons in SDS
Company Information
company name
Bartoline Limited Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
infor@bartoline.co.uk, info@bartoline.eu
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H318, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS05 GHS07
Signal word
Danger
Contains
Portland Cement Clinker, Flue Dust
Hazard statements
H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H318 - Causes serious eye damage. H335 - May cause respiratory irritation.
Precautionary statements
P264 - Wash hands, forearms and face thoroughly after handling. P271 - Use only outdoors or in a well-ventilated area. P280 - Wear protective clothing, eye protection, face protection, protective gloves. P302+P352 - IF ON SKIN: Wash with plenty of water. P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P260 - Do not breathe dust.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 1 H318 Skin sensitisation, Category 1 H317 Specific target organ toxicity – Single exposure, Category 3, Respiratory H335 tract irritation Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available
